Answer
A bispecific immunotherapy that connects T cells to CD19-positive B cells.
Sources for this answer
- BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.